Cairo Pharmaceuticals (CPCI.CA) - Release Concerning the Notification of Article 29
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release concerning the notification of Article 29 of EGX Listing Rules.
The Release (204 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release concerning the notification of Article 29 of EGX Listing Rules.
The Release (204 KB)
Comments